SunnyBay BioTech develops therapeutic antibodies to detect, diagnose, and treat cancer.
SunnyBay BioTech has raised $2.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.
SunnyBay BioTech is headquartered in Fremont, United States.
SunnyBay BioTech develops therapeutic antibodies to detect, diagnose, and treat cancer.
SunnyBay BioTech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SunnyBay BioTech — Funding & Investors." VCBacked, January 26, 2023, https://www.vcbacked.co/company/sunnybay-biotech. Accessed September 30, 2026.
VCBacked. (2023). SunnyBay BioTech — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sunnybay-biotech
{{cite web |title=SunnyBay BioTech — Funding & Investors |url=https://www.vcbacked.co/company/sunnybay-biotech |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated